Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...
Junior Mining Network

Cameco announces third quarter results: financial performance on track for strong finish to the year; nuclear fundamentals strengthened by transformational partnership to ...

All amounts in Canadian dollars unless specified otherwise SASKATOON, Saskatchewan / Nov 05, 2025 / Business Wire / Cameco (TSX: CCO; NYSE: CCJ) ...